Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma.
| Autor: | Alzibdeh A; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Mohamad I; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Al-Hussaini M; Department of Pathology, King Hussein Cancer Center, Amman, Jordan., Salah S; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Jaradat A; Faculty of Medicine, The University of Jordan, Amman, Jordan., Abuhijlih R; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Abuhijla F; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | World journal of oncology [World J Oncol] 2024 Feb; Vol. 15 (1), pp. 143-148. Date of Electronic Publication: 2023 Dec 09. |
| DOI: | 10.14740/wjon1748 |
| Abstrakt: | Uterine leiomyosarcoma is a high-grade sarcoma that might be associated with dismal outcome. There are no hematological markers that can be used to follow up the recurrence and/or progression of the tumor. We present a case of a 44-year-old female, who was diagnosed with uterine leiomyosarcoma. During her management course, serum beta human chorionic gonadotropin (β-hCG) elevation was correlated with clinical and radiological disease progression on two separate occasions. This correlation should be further investigated to potentially integrate serum β-hCG as a predictive tool for clinical behavior and treatment response. Competing Interests: All authors declare no conflict of interest. (Copyright 2024, Alzibdeh et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|